Extracellular Matrix Patches Market to Grow with a CAGR of 7.45% through 2029

Technological advancements in ECM production and advancements in surgical techniques is expected to drive the Global Extracellular Matrix Patches Market growth in the forecast period, 2025-2029

 

According to TechSci Research report, “Extracellular Matrix Patches Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2019-2029F”, the Global Extracellular Matrix Patches Market stood at USD 28.21 million in 2023 and is anticipated to grow with a CAGR of 7.45% through 2029F. The growth of the ECM Patches market can be attributed to their expanding applications across multiple medical specialties. ECM Patches are no longer confined to specific fields but are increasingly utilized in various medical disciplines, including cardiac surgery, orthopedics, wound care, and ophthalmology. As the scope of applications for ECM Patches widens, the market experiences corresponding growth.

Also, there is a growing demand for advanced medical solutions in developing regions. As healthcare infrastructure improves and access to regenerative therapies becomes more widespread in these areas, the ECM Patches market is expected to penetrate these regions. This trend presents growth opportunities for both established companies and emerging players in the market.

                                                                                             

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Extracellular Matrix Patches Market”

 

The rising utilization of extracellular matrix (ECM) in hernia and pelvic reconstruction surgeries is fueling the expansion of these products. Abdominal wall hernia repair, a prevalent surgical procedure globally, sees over 1 million annual surgeries in the United States alone, as reported by Medscape. Numerous companies are actively developing ECM solutions for pelvic reconstruction and hernia repair.

Recent technological advancements in ECM for soft tissue repair and wound healing procedures are driving the demand for these products. For instance, Aziyo Biologics' AltiPly, a ready-to-use patch, eliminates the need for rehydration and offers ease of handling at room temperature. Its proprietary processing enhances growth factors, accelerating the healing process, making it suitable for conditions like venous leg ulcers, diabetic foot ulcers, and pressure wounds. The high cost of ECM grafts may potentially impede market growth. However, government reimbursement programs continue to support demand. For example, the American Medical Association recognizes eight Current Procedural Terminology (CPT) codes for various applications of Smith & Nephew's OASIS Matrix products, which can be reimbursed in three settings: out-of-hospital (HOPD), physician in-office (QHP), and ambulatory wound care center (ASC).

Also, the increasing awareness of the benefits of biological patches over synthetic alternatives is a significant driver of ECM patch growth. However, recalls of some ECM products in recent years have hindered their adoption. Moreover, the use of extracellular matrix grafts may lead to various complications such as allergies, chronic inflammation, pain, swelling, and redness, which could adversely affect their growth.

The Global Extracellular Matrix Patches Market is segmented into application, raw material, regional distribution, and company.

Based on Raw Material, In 2023, porcine emerged as the dominant market segment, capturing a significant revenue share. Their widespread use in repair and reconstructive surgeries is attributed to their similarity to human collagen, reducing the risk of allergic reactions. These grafts offer several advantages, including durability, flexibility, and the ability to minimize scarring, all of which drive their demand. Additionally, their broad availability and high adoption rates contribute to the growth of this segment. ECM patches sourced from bovine origins are anticipated to exhibit the most rapid CAGR over the forecast period. This growth is driven by the increasing availability of bovine-based products and their expanding applications in various areas such as soft tissue repair, vascular repair and reconstruction, dural repair, pericardial repair, and others. Furthermore, these patches are preferred over alternative materials due to their superior biocompatibility, reduced infection risk, and ease of handling during surgical procedures. The segment is further bolstered by the high availability of cattle and the competitive pricing of these products.

Also, ECM patches derived from other sources, such as human-derived dermis and equine-derived pericardium, also held a significant market share in 2023. The growing number of research initiatives by private enterprises, coupled with substantial investments in research and development, has facilitated the adoption of alternative raw materials for ECM patch production. Moreover, numerous public and private organizations support the development of ECM grafts through the donation of human dermis. For instance, MTF Biologics, a non-profit organization, is actively involved in supplying human allograft tissue. One of their products, the AlloPatch HD Acellular Dermis, is a human allograft sourced from donated human tissue.

Based on Region, The Asia Pacific region is poised to achieve the fastest Compound Annual Growth Rate (CAGR) during the forecast period. This accelerated growth is attributed to several factors, including the high prevalence of cardiovascular diseases, an increasing incidence of trauma cases, and a rising number of surgeries across the region. For example, statistics indicate that approximately 200,000 infants are born in India each year with congenital cardiac disease, occurring at a frequency of 9 out of every 1,000 births. Approximately one-fifth of these infants are likely to have significant defects requiring treatment during their first year of life. As healthcare expenditure in the region continues to climb and the burden of disease escalates, the demand for ECM patches is anticipated to surge in the coming years. However, it is essential to note that the relatively high cost of the product may pose a potential challenge to growth in this region.

 

Major companies operating in Global Extracellular Matrix Patches Market are:

• Cook Group Inc
• Coloplast Corp
• Smith & Nephew PLC
• Koninklijke DSM N.V.
• MTF Biologics
• Boston Scientific Corp
• Medtronic PLC
• Baxter International Inc

 

Download Free Sample Report

Customers can also request for 10% free customization on this report

 

“The future of the Global Extracellular Matrix (ECM) Patches Market is teeming with potential. As regenerative medicine continues to advance, customization and combination therapies become the norm, and regulatory approval processes become more efficient, ECM Patches are poised to play an increasingly vital role in healthcare. The market's expansion into developing regions and the ongoing research and development efforts ensure that ECM Patches remain at the forefront of medical innovation, offering hope to millions of patients worldwide. The evolution of ECM Patches reflects the broader shift towards personalized and regenerative medicine, promising a brighter and more patient-centered future for healthcare”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Extracellular Matrix Patches Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Cardiac repair, Vascular repair & reconstruction, Pericardial repair, Dural repair, Soft tissue repair, Wound healing), By Raw material (Bovine, Porcine, Others), By Region, and By Competition, 2019-2029F”, has evaluated the future growth potential of Global Extracellular Matrix Patches Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Extracellular Matrix Patches Market.

 

Contact Us-

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

M: +13322586602

Email: [email protected]

Website: www.techsciresearch.com